Risteys · CD2_BENIGN_CONNSOFT

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D21.5& Hospital discharge: ICD-9 — 2156 Cause of death: ICD-10 — D21.5& Cause of death: ICD-9 — 2156 2 out of 7 registries used, show all original rules.	102
4. Check minimum number of events None	102
5. Include endpoints None	102
6. Filter based on genotype QC (FinnGen only)	95

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	614	406	205
Only index persons	554	380	174
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	45.09	45.18	44.60
Only index persons	43.82	44.74	41.82

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	95	68	27
Unadjusted period prevalence (%)	0.02	0.02	0.01
Median age at first event (years)	46.87	47.17	46.12

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
96: Matched controls
960

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D21.5

ICD-10 Finland

Benign neoplasm: Connective and other soft tissue of pelvis

+∞

119.1

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

8.4

9.1

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

4.4

6.4

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40768804) Tissue Pathology biopsy report

335

2.85

5.85

2.6

2.1

—

(4035726) Immunohistochemistry procedure

2.98

4.03

1.6

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

264

2.33

3.95

2.8

2.6

—

(3032080) INR in Blood by Coagulation assay

319

2.28

3.81

9.7

10.9

1.10

1.14

inr

0.28

257

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2.79

3.48

2.3

4.7

2.49

11.43

ug/l

1.73

(3000492) Spirometry study

2.31

2.54

1.9

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

190

2.03

2.53

2.8

2.7

—

(3016018) Differential panel - Cerebral spinal fluid

5.79

2.24

1.0

1.1

—

(3044941) Cell count panel - Synovial fluid

5.79

2.24

1.4

—

(3021788) Differential panel - Synovial fluid

5.79

2.24

1.0

1.6

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2.58

2.23

4.0

6.1

71.61

72.26

ng/l

0.02

(42870588) Differential panel, method unspecified - Blood

275

1.86

2.23

9.7

6.8

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

787

2.79

2.20

5.3

5.5

1.75

1.85

mu/l

0.39

733

(3002256) Pathology report gross observation

114

2.08

1.2

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

3.51

2.00

1.0

1.3

—

(3013115) Eosinophils [#/volume] in Blood

444

1.77

1.96

10.5

7.5

0.20

0.17

e9/l

0.52

392

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

3.02

1.91

1.3

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

2.08

1.86

4.9

9.4

105.22

104.32

mmol/l

0.47

(3013826) Glucose [Moles/volume] in Serum or Plasma

459

1.74

1.84

4.9

5.3

6.35

6.41

mmol/l

0.10

429

(3019150) Specific gravity of Urine by Refractometry

193

1.81

4.9

4.0

1.02

kg/l

0.26

125

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

347

1.69

1.74

2.3

1.9

95.41

99.23

pmol/l

0.16

170

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

204

1.77

1.73

3.1

2.1

3.43

2.92

mg/l

0.46

181

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

138

1.88

1.72

2.3

3.3

42.08

173.22

ng/l

0.86

(3018095) Leukocytes [#/volume] in Urine

322

1.68

1.67

6.1

4.2

22.59

43.88

e6/l

0.84

217

(3035350) Ketones [Presence] in Urine by Test strip

457

1.68

1.65

4.9

3.9

0.00

estimate

-0.00

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

3.13

1.61

2.7

3.0

12.17

50.63

u/ml

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

391

1.65

1.60

3.2

3.1

—

estimate

—

(3022096) Basophils/Leukocytes in Blood

402

1.64

1.57

10.9

7.2

0.75

0.66

0.37

377

(3013512) EKG study

236

1.68

1.55

2.7

3.5

—

(3019198) Lymphocytes [#/volume] in Blood

442

1.64

1.55

10.6

7.3

1.80

1.90

e9/l

0.36

396

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

2.98

1.53

1.0

1.2

—

(3002030) Lymphocytes/Leukocytes in Blood

415

1.62

1.50

10.8

7.2

27.25

28.59

0.36

399

(3001604) Monocytes [#/volume] in Blood

426

1.61

1.47

10.8

7.3

0.58

0.57

e9/l

0.05

372

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

2.84

1.46

1.2

1.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

223

1.65

1.43

1.9

1.6

23.84

20.74

nmol/l

0.45

184

(3006315) Basophils [#/volume] in Blood

429

1.59

1.41

10.8

7.2

0.04

e9/l

0.61

373

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1.99

1.38

1.7

2.9

0.24

0.21

g/l

0.60

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

141

1.73

1.32

2.5

2.1

—

(3006504) Eosinophils/Leukocytes in Blood

404

1.56

1.32

11.1

7.1

2.80

2.58

0.27

382

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

291

1.57

1.30

2.9

3.7

31.29

32.19

ng/l

0.02

175

(3026008) Bacteria identified in Urine by Culture

240

1.57

1.22

4.7

2.9

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

823

2.12

1.21

23.5

14.8

18.94

20.23

mg/l

0.19

655

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.12

1.21

1.1

1.0

—

(3018010) Neutrophils/Leukocytes in Blood

410

1.52

1.20

11.0

7.0

57.35

57.14

0.03

395

(3013650) Neutrophils [#/volume] in Blood by Automated count

481

1.52

1.16

14.5

12.0

4.17

3.94

e9/l

0.32

418

(4024509) Urine culture

2.44

1.15

3.6

2.0

—

(3015736) pH of Urine

365

1.50

1.13

4.2

3.4

6.35

6.17

0.52

197

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

337

1.50

1.12

5.0

3.7

0.30

0.00

estimate

—

(3000764) Benzodiazepines [Presence] in Urine

2.04

1.11

1.0

1.8

—

(3009261) Glucose [Presence] in Urine by Test strip

464

1.50

1.11

5.0

4.0

0.00

estimate

-0.00

(3028707) Methadone [Presence] in Urine by Screen method

2.45

1.10

1.0

2.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

752

1.77

1.08

6.0

5.6

38.52

38.45

mmol/mol

0.02

711

(3022948) Iron [Moles/volume] in Serum or Plasma

124

1.66

1.07

3.4

2.4

13.26

13.12

umol/l

0.03

116

(3019069) Monocytes/Leukocytes in Blood

408

1.47

1.05

11.2

7.3

8.63

8.62

0.01

387

(3021589) Normoblasts [#/volume] in Blood

389

1.47

1.04

12.6

11.8

0.00

e9/l

0.03

311

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

168

1.57

1.03

1.6

1.4

—

(3022313) Gas panel - Capillary blood

2.30

0.95

4.7

10.9

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

180

1.53

0.95

1.4

1.15

9.68

u/ml

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

155

1.54

0.92

3.0

2.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

367

1.43

0.91

1.8

1.9

1.42

1.37

mmol/l

0.16

316

(3027008) Opiates [Presence] in Urine

1.99

0.91

1.0

1.7

—

(3042936) Bacteria identified in Isolate by Culture

121

1.60

0.91

2.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

456

1.42

0.90

4.9

3.9

0.00

estimate

-0.00

(3027944) Amphetamines [Presence] in Urine

1.94

0.90

1.0

1.7

—

(3028300) Cannabinoids [Presence] in Urine

1.94

0.90

1.0

1.7

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

113

1.61

0.90

1.7

2.1

28.71

28.46

0.12

108

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

2.06

0.88

2.3

1.4

—

(3008898) HLA-B27 [Presence]

1.81

0.85

1.0

1.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.63

0.84

4.8

1.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.87

0.80

1.0

1.8

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.80

0.0

1.5

—

47.73

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

117

1.55

0.78

3.2

2.3

2.56

2.37

g/l

0.66

106

(4034850) Laboratory test

2.24

0.77

3.2

6.9

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2.24

0.77

6.0

12.7

22.46

24.42

mmol/l

—

(3023368) Bacteria identified in Blood by Culture

197

1.44

0.77

7.9

4.7

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.66

0.76

3.3

2.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1.91

0.75

1.9

2.7

38.29

43.27

u/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1.67

0.75

1.9

1.5

—

(3049717) Cytology report of Urine Cyto stain

2.05

0.74

3.8

1.9

—

(3016879) Cocaine [Presence] in Urine

1.81

0.73

1.0

1.7

—

(3012544) pH of Venous blood

1.64

0.72

5.0

6.4

7.37

7.39

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1.97

0.71

1.6

1.5

—

48.90

—

(3019977) pH of Arterial blood

1.59

0.70

6.5

8.1

7.43

7.41

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1.90

0.69

1.8

1.9

1.18

1.15

g/l

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

786

1.55

0.67

19.1

14.3

85.59

86.80

ml/min/173m2

0.18

722

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

193

1.40

0.67

1.4

1.9

0.43

1.42

mg/l

1.90

156

(40761511) CBC panel - Blood by Automated count

855

1.84

0.66

16.8

12.8

—

(3011288) Drugs identified in Urine by Screen method Nominal

1.76

0.64

1.0

1.7

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

133

1.43

0.60

2.4

1.9

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.50

0.60

2.3

1.8

—

(3041096) Erythrocytes [Presence] in Urine by Automated

256

1.31

0.54

4.3

3.1

0.00

0.01

estimate

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

256

1.31

0.54

1.2

1.3

0.51

1.65

u/ml

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

220

0.72

0.52

1.6

1.7

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.60

0.50

1.0

1.1

—

0.48

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.60

0.50

1.4

1.6

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1.60

0.50

1.0

1.2

0.89

0.81

g/l

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1.60

0.50

1.0

1.1

1.71

1.56

g/l

—

(3000991) Gas panel - Venous blood

1.53

0.49

8.0

11.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.48

0.48

3.3

3.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1.43

0.46

7.9

4.8

25.33

23.52

mmol/l

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

141

1.34

0.44

3.7

3.2

8.00

3.62

e6/l

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1.65

0.43

1.2

1.8

133.40

182.42

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.41

0.43

7.8

10.7

25.24

24.56

mmol/l

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1.54

0.42

2.0

1.6

—

(3042631) Mycobacterium sp identified in Specimen

0.00

0.41

0.0

3.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.00

0.41

0.0

4.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

0.41

0.0

1.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

237

1.26

0.40

2.3

1.4

2.22

2.45

g/l

0.23

150

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.41

0.39

2.2

2.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

191

1.27

0.38

1.4

10.90

19.25

iu/ml

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.38

0.38

4.0

2.3

—

(40758558) Short blood count panel - Blood

268

1.23

0.37

11.3

6.3

—

(3019060) Gas panel - Arterial blood

1.42

0.36

2.8

4.0

—

(3029937) Albumin [Presence] in Urine by Test strip

241

1.23

0.34

5.7

4.2

0.00

estimate

-0.00

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.36

0.34

1.5

1.8

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

214

1.23

0.32

1.8

2.1

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

111

1.31

0.32

3.9

2.4

20.44

22.47

0.32

103

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

600

1.20

0.31

4.1

3.4

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

714

1.23

0.31

29.7

19.0

332.33

331.94

g/l

0.13

714

(1761868) Lipid panel - Serum or Plasma

349

0.83

0.30

3.2

3.0

—

(3022145) Colonoscopy Study observation

1.32

0.30

1.2

1.4

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1.25

0.28

2.0

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.33

0.27

1.4

1.6

—

(40761536) Microorganisms panel - Urine sediment

1.33

0.27

5.4

3.5

—

(40768797) Stomach Pathology biopsy report

116

1.24

0.23

1.9

1.2

—

(3000494) Fungus identified in Specimen by Culture

107

1.25

0.23

1.4

—

(40768443) Skin Pathology biopsy report

1.23

0.22

1.0

1.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

155

1.20

0.22

3.2

2.8

3.31

0.71

e6/l

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

0.21

0.0

1.5

—

(37208534) Antinuclear antibody arbitrary concentration in serum

0.00

0.21

0.0

1.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

0.21

0.0

2.6

—

(3037756) Immunofixation for Serum or Plasma

0.00

0.21

0.0

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

0.21

0.0

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.08

—

(3020682) Albumin/Creatinine [Ratio] in Urine

252

1.16

0.21

3.8

4.1

1.72

75.49

mg/mmol

0.53

158

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

2.9

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

0.21

0.0

4.1

—

31.54

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.8

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

0.21

0.0

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

0.21

0.0

1.0

—

(3000012) Reticulocyte production index

0.00

0.20

0.0

3.8

—

0.93

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.22

0.18

1.4

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

120

1.20

0.17

4.5

5.0

18.64

23.70

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

0.76

0.16

10.2

7.3

—

(36660697) Celiac disease serology panel - Serum

0.82

0.14

1.0

1.1

—

(21494755) Public health laboratory ask at order entry panel

0.79

0.14

1.9

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

190

1.13

0.14

1.5

1.7

—

(3018418) pH of Serum or Plasma

260

1.11

0.12

10.2

4.3

7.39

7.40

0.61

183

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.16

0.11

2.6

1.9

—

(3014007) Fractional oxyhemoglobin in Arterial blood

1.04

0.09

7.0

12.1

94.66

95.17

—

(3025941) Bacteria identified in Stool by Culture

1.06

0.08

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

127

0.94

0.02

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

128

1.02

0.00

1.8

1.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

208

1.01

0.00

4.7

7.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

133

0.97

0.00

2.2

1.6

—

(3003694) ABO and Rh group [Type] in Blood

269

1.01

0.00

1.8

1.6

—

(3012516) Albumin [Mass/volume] in Urine

249

1.01

0.00

4.0

3.4

15.71

32.55

mg/l

1.03

157

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.01

0.00

2.3

1.8

—

(3037522) Nuclear Ab [Titer] in Serum

131

0.99

0.00

1.8

1.5

493.33

600.00

titre

—

(4211845) Urine protein measurement

0.00

-0.00

0.0

1.8

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

15.6

—

1485.44

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

-0.00

0.0

3.6

—

106.75

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

2.5

—

4.48

—

(3017569) Oxygen content in Arterial blood

0.00

-0.00

0.0

1.4

—

15.98

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(3002619) Bacteria identified in Specimen by Culture

0.00

-0.00

0.0

1.5

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1.02

-0.00

7.0

11.6

0.74

0.62

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

0.00

-0.00

0.0

1.3

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

11.0

—

0.56

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(4146454) Self-monitoring of blood glucose

0.00

-0.00

0.0

2.8

—

(1002224) Polysomnography panel

0.89

-0.00

1.4

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(21491868) Cryoglobulin [Mass/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

0.92

-0.00

4.3

2.9

0.60

0.86

ug/l

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

0.00

-0.00

0.0

1.5

—

13.40

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

12.3

—

846.00

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

-0.00

0.0

3.6

—

1.21

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

-0.00

0.0

3.6

—

4.09

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.00

-0.00

0.0

1.4

—

(3045142) Bone marrow Pathology biopsy report

0.00

-0.00

0.0

1.6

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

0.00

-0.00

0.0

1.3

—

407.76

—

(44806420) Estimation of glomerular filtration rate

0.00

-0.00

0.0

2.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

-0.00

0.0

1.0

—

(3006462) Nitrate [Presence] in Urine

0.00

-0.00

0.0

2.0

—

(21494434) Karyotype in Bone marrow

0.00

-0.00

0.0

1.0

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

105.44

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

2.5

—

10.65

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

0.00

-0.00

0.0

3.8

—

21.72

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1.00

-0.00

7.0

11.6

2.14

1.27

—

(3006653) Thiamine [Moles/volume] in Blood

0.00

-0.00

0.0

1.0

—

140.20

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

0.00

-0.00

0.0

1.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3016038) Potassium [Moles/volume] in Urine

0.00

-0.00

0.0

3.6

—

32.20

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.00

-0.00

0.0

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

-0.00

0.0

1.4

—

6.12

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

-0.00

0.0

1.0

—

NAME	CD2_BENIGN_CONNSOFT_PELVIS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D215
HD_ICD_9	2156
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D215
COD_ICD_9	2156
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Benign neoplasm: Connective and other soft tissue of pelvis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints